Exploring gene-environment interactions in Parkinson's disease.

Human Genetics
Colin C McCullochHaydeh Payami

Abstract

The objective of this study was to explore combined effects of four candidate susceptibility genes and two exposures on Parkinson's disease (PD) risk; namely, alpha-synuclein (SNCA) promoter polymorphism REP1, microtubule-associated protein tau (MAPT) H1/H2 haplotypes, apolipoprotein E (APOE) epsilon2/epsilon3/epsilon4 polymorphism, ubiquitin carboxy-terminal esterase L1 (UCHL1) S18Y variant, cigarette smoking and caffeinated coffee consumption. 932 PD patients and 664 control subjects from the NeuroGenetics Research Consortium, with complete data on all six factors, were studied. Uniform protocols were used for diagnosis, recruitment, data collection and genotyping. A logistic regression model which included gene-exposure interactions was applied. Likelihood ratio tests (LRTs) were used for significance testing and Bayesian inference was used to estimate odds ratios (ORs). MAPT (P = 0.007), SNCA REP1 (P = 0.012), smoking (P = 0.001), and coffee (P = 0.011) were associated with PD risk. Two novel interactions were detected: APOE with coffee (P = 0.005), and REP1 with smoking (P = 0.021). While the individual main effects were modest, each yielding OR < 1.6, the effects were cumulative, with some combinations reaching OR = 12.6 ...Continue Reading

References

Jun 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·W R Gibb, A J Lees
Oct 20, 2001·Brain Research·M Quik, D A Di Monte
Apr 24, 2002·Neurology·Michael A SchwarzschildAlberto Ascherio
Sep 3, 2002·Annals of Neurology·Miguel A HernánJuan J Gestal-Otero
Feb 8, 2003·Annual Review of Neuroscience·Richard Mayeux
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
Mar 30, 2004·Annals of Neurology·Demetrius M MaraganoreUNKNOWN UCHL1 Global Genetics Consortium
Jan 4, 2005·European Neurology·Jun ZhangDongsheng Fan
Mar 29, 2005·Nature Genetics·Jonathan MarchiniLon R Cardon
Feb 2, 2006·Annals of Neurology·Daniel G HealyNicholas W Wood
May 20, 2006·Biochemical Society Transactions·J E VanceH Hayashi
Jun 30, 2006·Journal of the Neurological Sciences·Anti KaldaJiang-Fan Chen
Aug 3, 2006·Journal of Neurochemistry·Maryka QuikDonato A Di Monte
Aug 10, 2006·JAMA : the Journal of the American Medical Association·Demetrius M MaraganoreUNKNOWN Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium
Oct 28, 2006·Annals of Neurology·John HardyAndrew Singleton
May 22, 2007·Annals of Neurology·Cyrus P ZabetianHaydeh Payami
Jul 12, 2007·JAMA : the Journal of the American Medical Association·Eric J TopolKelly A Frazer
Nov 8, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Karen M PowersHaydeh Payami
Dec 21, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Carolyn M HutterCyrus P Zabetian

❮ Previous
Next ❯

Citations

Jul 30, 2011·Neurogenetics·Lasse Pihlstrøm, Mathias Toft
Oct 1, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yoland SmithMahlon R DeLong
Oct 25, 2008·Nucleic Acids Research·Suisheng TangSee Kiong Ng
Feb 12, 2011·Annals of Human Genetics·Megan W ButlerLiyong Wang
Jul 31, 2012·BMC Neurology·Yoshihiro MiyakeUNKNOWN Fukuoka Kinki Parkinson’s Disease Study Group
Sep 15, 2010·Psychiatry Research·Péter Z AlmosJános Kálmán
Aug 6, 2011·Parkinsonism & Related Disorders·Joanna M BiernackaDemetrius M Maraganore
Dec 21, 2010·Parkinsonism & Related Disorders·Chin-Hsien LinFu-Chang Hu
Nov 6, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ying LiuJi-Yu Cao
Aug 30, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Chunlei LiSheng Bi
Jul 25, 2013·Neuroscience Letters·Rita TörökPeter Klivenyi
Nov 23, 2011·Parkinsonism & Related Disorders·Luca TrottaRosanna Asselta
Dec 12, 2012·Neurochemistry International·Claudia FunkeDouglas B Kell
Jul 13, 2016·Human Molecular Genetics·Erin M Hill-BurnsHaydeh Payami
Aug 22, 2013·Neurobiology of Aging·Michael G HeckmanUNKNOWN Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium
Jul 30, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·G O SkeieO B Tysnes
Mar 31, 2019·Disease Models & Mechanisms·Teresa R Taylor-WhiteleyDavid P Smith
Jan 2, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Greg T SutherlandGeorge D Mellick
Jun 3, 2011·European Journal of Epidemiology·Karin WirdefeldtJack Mandel
Jun 30, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Stewart A FactorHaydeh Payami
Mar 11, 2011·Annals of Neurology·Alexis ElbazUNKNOWN Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium
Jan 26, 2012·Annals of Neurology·Samuel M GoldmanCaroline M Tanner
Jul 12, 2017·Frontiers in Cellular Neuroscience·Xiong ZhangJian-Hong Zhu
Jul 7, 2017·Translational Neurodegeneration·Chaoran MaXiang Gao
Mar 8, 2016·Neurogenetics·L Tagliafierro, O Chiba-Falek
Jul 1, 2016·Comprehensive Reviews in Food Science and Food Safety·L Kirsty PourshahidiJ J Strain
Feb 15, 2021·Annals of Neurology·Yann Le GuenMichael D Greicius

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Karen M PowersHaydeh Payami
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Denise M KayHaydeh Payami
Human Genetics
Nathan PankratzPSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories
© 2021 Meta ULC. All rights reserved